Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1174

Feb 1, 2022

Adventures in Technophilosophy: On the Reality of Virtual Worlds

Posted by in categories: biotech/medical, computing, education, food

When I was ten years old, I discovered computers. My first machine was a PDP-10 mainframe system at the medical center where my father worked. I taught myself to write simple programs in the BASIC computer language. Like any ten-year-old, I was especially pleased to discover games on the computer. One game was simply labeled “ADVENT.” I opened it and saw:

You are standing at the end of a road before a small brick building. Around you is a forest. A small stream flows out of the building and down a gully.

I figured out that I could move around with commands like “go north” and “go south.” I entered the building and got food, water, keys, a lamp. I wandered outside and descended through a grate into a system of underground caves. Soon I was battling snakes, gathering treasures, and throwing axes at pesky attackers. The game used text only, no graphics, but it was easy to imagine the cave system stretching out below ground. I played for months, roaming farther and deeper, gradually mapping out the world.

Feb 1, 2022

Aspirin recall: There’s a poisoning risk with these recalled meds, so check your home now

Posted by in category: biotech/medical

Geri-Care issued a recall for some aspirin and acetaminophen bottles that are not child-resistant, posing a poisoning risk.


Aspirin and acetaminophen are over-the-counter drugs that countless people have in their medicine cabinets. Many people use them to alleviate pain and reduce fevers, and these drugs might be the first course of action when exhibiting such symptoms. That’s what makes them popular purchases with consumers. And that’s why buyers should pay extra close attention to recalls that involve aspirin and acetaminophen products.

A new recall action involves bottles of Geri-Care Pharmaceuticals aspirin and acetaminophen, as they pose a risk of poisoning to children who might get their hands on these common drugs.

Continue reading “Aspirin recall: There’s a poisoning risk with these recalled meds, so check your home now” »

Feb 1, 2022

Artificial intelligence system rapidly predicts how two proteins will attach

Posted by in categories: biotech/medical, health, robotics/AI

The machine-learning model could help scientists speed the development of new medicines.

This technique could help scientists better understand some biological processes that involve protein interactions, like DNA replication and repair; it could also speed up the process of developing new medicines.

“Deep learning is very good at capturing interactions between different proteins that are otherwise difficult for chemists or biologists to write experimentally. Some of these interactions are very complicated, and people haven’t found good ways to express them. This deep-learning model can learn these types of interactions from data,” says Octavian-Eugen Ganea, a postdoc in the MIT Computer Science and Artificial Intelligence Laboratory (CSAIL) and co-lead author of the paper.

Continue reading “Artificial intelligence system rapidly predicts how two proteins will attach” »

Feb 1, 2022

A DAO Wants To Inject Bitcoin Into Mouse DNA via a Genetically Modified Virus

Posted by in categories: biotech/medical, bitcoin, genetics

Feb 1, 2022

AI nanny created by Chinese scientists to grow humans in robot wombs

Posted by in categories: biotech/medical, ethics, information science, robotics/AI

The AI nanny is here! In a new feat for science, robots and AI can now be paired to optimise the creation of human life. In a Matrix-esque reality, robotics and artificial intelligence can now help to develop babies with algorithms and artificial wombs.

Reported by South China Morning Post, Chinese scientists in Suzhou have developed the new technology. However, there are worries surrounding the ethics of actually artificially growing human babies.

Feb 1, 2022

Dr Kevin Perrott, PhD — Founder & CEO — OpenCures — Accelerating Research To Prevent & Cure Disease

Posted by in categories: biotech/medical, chemistry, engineering, life extension, policy

Accelerating Research To Prevent & Cure Disease — Dr. Kevin Perrott, Ph.D., Founder & CEO, OpenCures; Co-Founder & Treasurer, SENS Research Foundation


Dr. Kevin Perrott, Ph.D. is Founder and CEO, OpenCures (https://opencures.org/), Adjunct Professor, University of Alberta, Co-Founder and Advisor, Oisin Biotechnologies, President, of Global Healthspan Policy Institute, and Co-Founder and Treasurer, SENS Research Foundation.

Continue reading “Dr Kevin Perrott, PhD — Founder & CEO — OpenCures — Accelerating Research To Prevent & Cure Disease” »

Jan 31, 2022

Scientists Successfully Turned Used Masks into Lithium-Ion Density Batteries

Posted by in category: biotech/medical

And they’re low-cost and disposable.

With the emergence of the COVID-19 pandemic, humans have become reliant on personal protection equipment, or PPE, more and more with each wave of infection. While single-use face masks make up a large portion of PPE around the world, not much thought has been given to the proper disposal of these products.

While these products are crucial in our fight against COVID-19, they undoubtedly take a toll on the environment, ending up in landfills and oceans, giving off toxic gases. In only 2020, 52 billion face masks were made and 1.56 billion of them ended up in our oceans. they’re low-cost and disposable.

Jan 31, 2022

The Future Of Medicine: Fighting Deadly Diseases With Smart Devices And Digital Biomarkers

Posted by in categories: biotech/medical, genetics, health, mobile phones, neuroscience

What are biomarkers? They are medical signals that can measure health in an accurate and reproducible way. Common examples include blood pressure readings, heart rate, and even genetic test results.

Modern digital devices measure several health parameters. Fitbit trackers use sensors such as accelerometers to tell how many steps we’ve taken in a day or how fast we’ve been walking. When can such novel health measures function as medical biomarkers?

Continue reading “The Future Of Medicine: Fighting Deadly Diseases With Smart Devices And Digital Biomarkers” »

Jan 31, 2022

Neuroscience research suggests a shared mechanism underlies both sleep disturbance and mental disorders

Posted by in categories: biotech/medical, neuroscience, nuclear energy

New research published in Human Brain Mapping provides evidence of a shared neural mechanism that underlies sleep disturbance and mental disorders in preadolescents. The findings indicate that sleep disturbance and mental health problems are both related to the connectivity between and within two important brain networks.

“I noticed the importance of sleep years ago when I read several papers about the immediate amyloid protein deposition in the brain after short-term sleep deprivation. Amyloid is neurotoxic waste in the brain and needs to be transported out by cerebrospinal fluid,” said study author Ze Wang, an associate professor of diagnostic radiology and nuclear medicine at the University of Maryland School of Medicine.

“But cerebrospinal fluid is basically static most of the time. The best time to have more cerebrospinal fluid and increased flow rate is at night when you lay down and fall asleep. It is this time that our cerebral blood flow reduces. Because our brain has a fixed size, the reduction of cerebral blood flow creates space for cerebrospinal fluid and the inhomogeneous change of blood flow creates power for cerebrospinal fluid to flow and then transport the neural waste out. This is why our brain generates two times as much cerebrospinal fluid at night than daytime.”

Jan 31, 2022

China names blockchain trial zones after its crackdown on cryptocurrencies

Posted by in categories: biotech/medical, blockchains, cryptocurrencies, finance, government

China has designated some cities and entities to trial blockchain applications, underscoring the importance Beijing is attaching to this particular technology.

In 2019, President Xi Jinping called on China to “seize the opportunities” presented by blockchain, giving his personal backing to the technology.

The Chinese capital Beijing and mega city Shanghai as well as Guangzhou in the south are all part of the pilot projects. Local government departments, universities, banks, hospitals, car companies and power firms are among the 164 entities chosen by China to carry out trial blockchain applications.